| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 1 | |
| #5 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Fermentation | |
| #3 | Therapeutic chemical compounds | |
| #4 | Climate change adaptation technologies | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Favre Daniel | 11 |
| Publication | Filing date | Title |
|---|---|---|
| EP1111040A1 | Infection of eukaryotic cells with viruses in vitro | |
| EP0953055A1 | Production of biologically active polypeptides | |
| AU4769197A | Inhibition of cap-independent protein synthesis by heparin or heparin mimetics thereof | |
| AU4196897A | Cell-free translational extract from eukaryotic cells that have grown in monolayers |